Glaxosmithkline Pharmaceuticals Ltd Results

Glaxosmithkline Pharmaceuticals Ltd’s revenue jumped 10.86% since last year same period to ₹1,091.36Cr in the Q3 2025-2026. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 7.4% jump in its revenue since last 3-months.

Glaxosmithkline Pharmaceuticals Ltd’s net profit jumped 28.6% since last year same period to ₹295.62Cr in the Q3 2025-2026. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 14.81% jump in its net profits since last 3-months.

Glaxosmithkline Pharmaceuticals Ltd’s net profit margin jumped 16% since last year same period to 27.09% in the Q3 2025-2026. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 6.9% jumped in its net profit margins since last 3-months.